{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:15:41Z","timestamp":1777490141743,"version":"3.51.4"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","award":["2021.06135"],"award-info":[{"award-number":["2021.06135"]}],"id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CENTRO-01\u20130145-FEDER-030752"],"award-info":[{"award-number":["CENTRO-01\u20130145-FEDER-030752"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["CB06\/05\/2004"],"award-info":[{"award-number":["CB06\/05\/2004"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-122473OA-I00"],"award-info":[{"award-number":["PID2021-122473OA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.arr.2023.101998","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T02:29:45Z","timestamp":1688524185000},"page":"101998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Under the umbrella of depression and Alzheimer\u2019s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?"],"prefix":"10.1016","volume":"90","author":[{"given":"Carla","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-6639","authenticated-orcid":false,"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2023.101998_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: A multi-scale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.arr.2023.101998_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102331","article-title":"Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: integration of the glutamate\/GABA-glutamine cycle","volume":"217","author":"Andersen","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031869","article-title":"Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer\u2019s Disease Progression","volume":"24","author":"Andronie-Cioara","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB 2: A cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.arr.2023.101998_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2018.09.016","article-title":"Insulin-like Growth Factor (IGF)-1 treatment stabilizes the microvascular cytoskeleton under ischemic conditions","volume":"311","author":"Bake","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2023.101998_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jad.2017.07.008","article-title":"Trajectories of depressive symptoms and their relationship to the progression of dementia","volume":"222","author":"Barca","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2023.101998_bib12","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cercor\/bhs154","article-title":"Age-based comparison of human dendritic spine structure using complete three-dimensional reconstructions","volume":"23","author":"Benavides-Piccione","year":"2013","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.arr.2023.101998_bib13","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer\u2019s Disease Brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12888-019-2237-x","article-title":"Clinical guidelines for the management of treatment-resistant depression","volume":"19","author":"Bennabi","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00213-016-4214-0","article-title":"Role of neuro-immunological factors in the pathophysiology of mood disorders","volume":"233","author":"Bhattacharya","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arr.2023.101998_bib16","series-title":"Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders","author":"Bicker","year":"2020"},{"key":"10.1016\/j.arr.2023.101998_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2013.12.009","article-title":"Genetic mouse models of brain ageing and Alzheimer\u2019s disease","volume":"142","author":"Bilkei-Gorzo","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.arr.2023.101998_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a Potential Treatment for Anxiety Disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.101998_bib19","doi-asserted-by":"crossref","unstructured":"Bomfim, T.R., Forny-germano, L., Sathler, L.B., Brito-moreira, J., Houzel, J., Decker, H., Silverman, M.A., Kazi, H., Melo, H.M., Mcclean, P.L., Holscher, C., Arnold, S.E., Talbot, K., Klein, W.L., Munoz, D.P., Ferreira, S.T., Felice, F.G. De, 2012. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013 associated A\u03b2 oligomers. J. Clin. Invest. 122, 1339\u20131353. https:\/\/doi.org\/10.1172\/JCI57256.","DOI":"10.1172\/JCI57256"},{"key":"10.1016\/j.arr.2023.101998_bib20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00213-015-4105-9","article-title":"Crosstalk between endocannabinoid and immune systems: A potential dysregulation in depression?","volume":"233","author":"Boorman","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arr.2023.101998_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.25049","article-title":"Dendritic spines provide cognitive resilience against Alzheimer\u2019s disease","volume":"82","author":"Boros","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2023.101998_bib22","doi-asserted-by":"crossref","unstructured":"Borroni, B., Archetti, S., Costanzi, C., Grassi, M., Ferrari, M., Radeghieri, A., Caimi, L., Caltagirone, C., Luca, M. Di, Padovani, A., 2009. Role of BDNF Val66Met functional polymorphism in Alzheimer\u2019s disease-related depression. Neurobiol. Aging 30, 1406\u20131412. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.11.023\u200b.","DOI":"10.1016\/j.neurobiolaging.2007.11.023"},{"key":"10.1016\/j.arr.2023.101998_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.psyneuen.2016.02.028","article-title":"Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users","volume":"68","author":"Bot","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.arr.2023.101998_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24544","article-title":"High Resolution Dissection of Reactive Glial Nets in Alzheimer\u2019s Disease","volume":"6","author":"Bouvier","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.101998_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arr.2023.101998_bib26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","article-title":"Mechanisms of secretion and spreading of pathological tau protein","volume":"77","author":"Brunello","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2023.101998_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biopsych.2005.09.022","article-title":"BDNF Val 66 Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects","volume":"59","author":"Bueller","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pnpbp.2018.01.026","article-title":"Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD","volume":"84","author":"Burstein","year":"2018","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40263-020-00705-9","article-title":"Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer\u2019s Disease","volume":"34","author":"Caffino","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2023.101998_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","article-title":"Stress and neuroinflammation: A systematic review of the effects of stress on microglia and the implications for mental illness","volume":"233","author":"Calcia","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arr.2023.101998_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2023.101998_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3233\/JAD-140093","article-title":"The potential therapeutic effects of THC on Alzheimer\u2019s disease","volume":"42","author":"Cao","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer\u2019s disease\u202f: Neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2023.101998_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tins.2005.06.005","article-title":"The many faces of CREB","volume":"28","author":"Carlezon","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.arr.2023.101998_bib36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13311-017-0537-8","article-title":"Vagal Nerve Stimulation for Treatment-Resistant Depression","volume":"14","author":"Carreno","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.101998_bib37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-130050","article-title":"Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy","volume":"35","author":"Casarejos","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib39","doi-asserted-by":"crossref","unstructured":"Chen, Z., Patel, P.D., Sant, G., Meng, C., Teng, K.K., Hempstead, B.L., Lee, F.S., 2004. Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons. J. Neurosci. 24, 4401\u20134411. https:\/\/doi.org\/10.1523\/JNEUROSCI.0348-04.2004.","DOI":"10.1523\/JNEUROSCI.0348-04.2004"},{"key":"10.1016\/j.arr.2023.101998_bib40","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arr.2023.101998_bib41","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19931-2","article-title":"Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system","volume":"11","author":"Chevalier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.101998_bib43","doi-asserted-by":"crossref","first-page":"34660","DOI":"10.1074\/jbc.M112.373241","article-title":"Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes","volume":"287","author":"Chicca","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.101998_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pnpbp.2019.01.005","article-title":"Dendritic spines: Revisiting the physiological role","volume":"92","author":"Chidambaram","year":"2019","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib45","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble \u03b2amyloid 1-42\u202f: a critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe \/PS1\u0394E9 Transgenic Female Mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2012.12.017","article-title":"Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia","volume":"29","author":"Couch","year":"2013","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.arr.2023.101998_bib48","first-page":"1","article-title":"Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine\u2019s Antidepressant Effect","author":"Cui","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib49","first-page":"1","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimer\u2019s Dement","volume":"6","author":"Cummings","year":"2020","journal-title":"Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2023.101998_bib50","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimer\u2019s Dement","volume":"8","author":"Cummings","year":"2022","journal-title":"Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2023.101998_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment Combinations for Alzheimer\u2019s Disease: Current and Future Pharmacotherapy Options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-008-1333-2","article-title":"Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans","volume":"202","author":"D\u2019Souza","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arr.2023.101998_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/physiol.00021.2016","article-title":"Expression and processing of amyloid precursor protein in vascular endothelium","volume":"32","author":"D\u2019Uscio","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.arr.2023.101998_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.17219\/acem\/149897","article-title":"Aging, depression and dementia: The inflammatory process","volume":"31","author":"Del Pilar Carrera-Gonzalez","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.arr.2023.101998_bib56","unstructured":"Depression and Other Common Mental Disorders: Global Health Estimates Geneva.: World Health Organization 2017."},{"key":"10.1016\/j.arr.2023.101998_bib57","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The Endocannabinoid System and its Modulation by Phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.101998_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1503\/jpn.110185","article-title":"Hippocampal abnormalities of glutamate\/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden","volume":"38","author":"de Diego-Adeli\u00f1o","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A Meta-Analysis of Cytokines in Major Depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib60","doi-asserted-by":"crossref","unstructured":"Du, Y., Fu, M., Huang, Z., Tian, X., Li, J., Pang, Y., Song, W., Tian Wang, Y., Dong, Z., 2020. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23\/PS45 mouse model of Alzheimer\u2019s disease. Aging Cell 19, 1\u201312. https:\/\/doi.org\/10.1111\/acel.13113.","DOI":"10.1111\/acel.13113"},{"key":"10.1016\/j.arr.2023.101998_bib61","first-page":"1","article-title":"Spine synapse remodeling in the pathophysiology and treatment of depression","author":"Duman","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"338","key":"10.1016\/j.arr.2023.101998_bib62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic Dysfunction in Depression: Potential Therapeutic Targets","volume":"80","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.arr.2023.101998_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.arr.2023.101998_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits \u03b2-amyloid-induced tau protein hyperphosphorylation through Wnt\/\u03b2-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.arr.2023.101998_bib65","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2023.101998_bib67","series-title":"Pharmacological Strategies to Improve Dendritic Spines in Alzheimer\u2019s Disease","author":"Ettcheto","year":"2020"},{"key":"10.1016\/j.arr.2023.101998_bib68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/mp060066m","article-title":"A Molecular Link Between the Active Component of Marijuana and Alzheimer\u2019s disease Pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2023.101998_bib69","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awv288","article-title":"Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease","volume":"138","author":"Fan","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.arr.2023.101998_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03602532.2018.1428343","article-title":"Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems","volume":"50","author":"Fantegrossi","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2023.101998_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2021.114433","article-title":"Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways","volume":"185","author":"Florensa-Zanuy","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib73","series-title":"Medical Use of Cannabinoids, Drugs","author":"Fraguas-S\u00e1nchez","year":"2018"},{"key":"10.1016\/j.arr.2023.101998_bib74","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1096\/fj.09-132043","article-title":"Neuronal IGF\u20101 resistance reduces A\u03b2 accumulation and protects against premature death in a model of Alzheimer\u2019s disease","volume":"23","author":"Freude","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.arr.2023.101998_bib75","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/brain\/awx132","article-title":"The Alzheimer\u2019s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons","volume":"140","author":"George","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2023.101998_bib76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbadis.2017.01.023","article-title":"Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer\u2019s neuropathology and cognitive deficits","volume":"1863","author":"Gerenu","year":"2017","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.arr.2023.101998_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","article-title":"Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review","volume":"76","author":"Gibbons","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.arr.2023.101998_bib78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1570159X16666180702144644","article-title":"Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer\u2019s Disease","volume":"17","author":"Giuseppina","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib79","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.0343-15.2015","article-title":"Blocking IGF signaling in adult neurons alleviates alzheimer\u2019s disease pathology through amyloid-\u03b2 clearance","volume":"35","author":"Gontier","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101612","article-title":"Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: Past, present and future","volume":"77","author":"Gouveia","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.arr.2023.101998_bib82","unstructured":"Guest, P.C., 2018. Reviews on New Drug Targets in Age-Related Disorders."},{"key":"10.1016\/j.arr.2023.101998_bib83","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and \u03b3-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib85","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/brain\/awaa405","article-title":"Depression, dementia and immune dysregulation","volume":"144","author":"Hayley","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2023.101998_bib86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2011.10.032","article-title":"Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene-environment interactions, and epigenetics","volume":"233","author":"Heim","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2023.101998_bib87","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: The role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib88","doi-asserted-by":"crossref","first-page":"114892","DOI":"10.1016\/j.bcp.2021.114892","article-title":"Mechanisms of ketamine and its metabolites as antidepressants","volume":"197","author":"Hess","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating Endocannabinoids and N-Acyl Ethanolamines Are Differentially Regulated in Major Depression and Following Exposure to Social Stress","volume":"34","author":"Hill","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.arr.2023.101998_bib91","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neurobiolaging.2019.03.008","article-title":"Aging circadian rhythms and cannabinoids","volume":"79","author":"Hodges","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101998_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2017.08.005","article-title":"Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study","volume":"83","author":"Holmes","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib94","doi-asserted-by":"crossref","unstructured":"Holmes, C., Arranz, M., Collier, D., Powell, J., Lovestone, S., 2003. Depression in Alzheimer\u2019s disease: The effect of serotonin receptor gene variation. Am. J. Med. Genet. - Neuropsychiatr. Genet. 119 B, 40\u201343. https:\/\/doi.org\/10.1002\/ajmg.b.10068.","DOI":"10.1002\/ajmg.b.10068"},{"key":"10.1016\/j.arr.2023.101998_bib95","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble A\u03b2 oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib96","first-page":"712","article-title":"ADF\/Cofilin-Actin Rods in Neurodegenerative Diseases","volume":"352","author":"Hong","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.arr.2023.101998_bib97","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2008.01.013","article-title":"The Subspine Organization of Actin Fibers Regulates the Structure and Plasticity of Dendritic Spines","volume":"57","author":"Honkura","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib98","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: First Approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2023.101998_bib99","series-title":"Distribution of the Endocannabinoid System in the Central Nervous System, Endocannabinoids, Handbook of Experimental Pharmacology","author":"Hu","year":"2015"},{"key":"10.1016\/j.arr.2023.101998_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-2-9","article-title":"Regulation of TGF-\u03b2 receptor activity","volume":"2","author":"Huang","year":"2012","journal-title":"Cell Biosci"},{"key":"10.1016\/j.arr.2023.101998_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-28","article-title":"TGF-\u03b21 blockade of microglial chemotaxis toward A\u03b2 aggregates involves SMAD signaling and down-regulation of CCL5","volume":"7","author":"Huang","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2023.101998_bib102","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.arr.2023.101998_bib103","doi-asserted-by":"crossref","unstructured":"Hungund, B.L., Vinod, K.Y., Kassir, S.A., Basavarajappa, B.S., Yalamanchili, R., Cooper, T.B., Mann, J.J., Arango, V., 2004. Upregulation of CB1 receptors and agonist-stimulated [ 35S]GTP\u03b3S binding in the prefrontal cortex of depressed suicide victims. Mol. Psychiatry 9, 184\u2013190. https:\/\/doi.org\/10.1038\/sj.mp.4001376.","DOI":"10.1038\/sj.mp.4001376"},{"key":"10.1016\/j.arr.2023.101998_bib104","doi-asserted-by":"crossref","unstructured":"Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Rosa, M. Di, Izzo, A.A., 2004. Neuroprotective effect of cannabidiol , a non-psychoactive component from Cannabis sativa , on b -amyloid-induced toxicity in PC12 cells. J. Neurochem. 89, 134\u2013141. https:\/\/doi.org\/10.1111\/j.1471-4159.2003.02327.x.","DOI":"10.1111\/j.1471-4159.2003.02327.x"},{"key":"10.1016\/j.arr.2023.101998_bib105","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11427-020-1815-6","article-title":"Microglia in depression: current perspectives","volume":"64","author":"Jia","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.arr.2023.101998_bib106","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/alz.12126","article-title":"Shift work and incidence of dementia: A Danish Nurse Cohort study","volume":"16","author":"J\u00f8rgensen","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.arr.2023.101998_bib107","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.tips.2022.09.011","article-title":"Pharmacogenomics in treatment of depression and psychosis: an update","volume":"43","author":"Jukic","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094837","article-title":"Serotonin\u2014Its Synthesis and Roles in the Healthy and the Critically Ill","volume":"22","author":"Kanova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib109","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","article-title":"Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs","volume":"136","author":"Karege","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.arr.2023.101998_bib111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA Axis in Major Depression: Cortisol, Clinical Symptomatology, and Genetic Variation Predict Cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib112","doi-asserted-by":"crossref","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","article-title":"Trans-cellular Propagation of Tau Aggregation by Fibrillar Species*","volume":"287","author":"Kfoury","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.101998_bib113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijms24020911","article-title":"Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity","volume":"24","author":"Khavandi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biol"},{"key":"10.1016\/j.arr.2023.101998_bib115","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.euroneuro.2014.12.013","article-title":"IGF-I in major depression and antidepressant treatment response","volume":"25","author":"Kopczak","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib116","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity \u2013 Links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib118","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.arr.2023.101998_bib119","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.arr.2023.101998_bib120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2023.101998_bib121","first-page":"292","article-title":"Drug disease interactions\u202f: Role of inflammatory mediators in depression and variability in antidepressant drug response","volume":"9","author":"Kulmatycki","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib122","doi-asserted-by":"crossref","first-page":"101533","DOI":"10.1016\/j.arr.2021.101533","article-title":"Orchestration of the circadian clock and its association with Alzheimer\u2019s disease: Role of endocannabinoid signaling","volume":"73","author":"Kumar","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00365","article-title":"Insulin-like growth factor-1 and neuroinflammation","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib124","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: New treatment paradigms. Alzheimer\u2019s Dement","volume":"3","author":"Lanct","year":"2017","journal-title":"Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2023.101998_bib125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3233\/JAD-2010-100510","article-title":"Amyloid- \u03b2 Peptides in Plasma and Cognitive Decline After 1 Year Follow-Up in Alzheimer \u2019 s Disease Patients","volume":"21","author":"Laske","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib126","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF- \u03b21 in the pathophysiology of major depressive disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib127","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11064-021-03332-y","article-title":"Alzheimer\u2019s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation","volume":"46","author":"Lehmann","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2023.101998_bib128","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2023.101998_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-020-02636-7","article-title":"Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: Data from an open-label vortioxetine study","volume":"20","author":"Levada","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib131","doi-asserted-by":"crossref","first-page":"112163","DOI":"10.1016\/j.ejmech.2020.112163","article-title":"Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer\u2019s disease","volume":"192","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.arr.2023.101998_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1957407","article-title":"Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer\u2019s disease and their potential links in the pathogenesis","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.arr.2023.101998_bib133","first-page":"1","article-title":"The role of brain derived neurotrophic factor in central nervous system","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107494","article-title":"A hypothesis of monoamine (5-HT) \u2013 Glutamate\/GABA long neural circuit: Aiming for fast-onset antidepressant discovery","volume":"208","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.arr.2023.101998_bib135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer\u2019s Disease","volume":"85","author":"Lian","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib136","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib137","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1523\/JNEUROSCI.1184-06.2006","article-title":"Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting","volume":"26","author":"Liston","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2023.101998_bib139","first-page":"1","article-title":"The Role of NMDA Receptors in Alzheimer \u2019s Disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0706679105","article-title":"Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: Role of corticosterone-mediated apical dendritic atrophy","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2023.101998_bib141","article-title":"Aging, Cellular Senescence, and Alzheimer\u2019s Disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib142","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2023.101998_bib143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2202-13-87","article-title":"Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex","volume":"13","author":"Long","year":"2012","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.arr.2023.101998_bib144","series-title":"Handbook of Clinical Neurology, Geriatric Neurology","first-page":"231","article-title":"Alzheimer\u2019s disease","author":"Lopez","year":"2019"},{"key":"10.1016\/j.arr.2023.101998_bib145","series-title":"Major depression and the biological hallmarks of aging","first-page":"101805","author":"Lorenzo","year":"2023"},{"key":"10.1016\/j.arr.2023.101998_bib146","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.arr.2023.101998_bib147","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","article-title":"The new \u201c5-HT\u201d hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to th","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib148","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2023.101998_bib149","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib150","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib151","doi-asserted-by":"crossref","unstructured":"Mecca, A.P., Toyonaga, T., Zhao, W., Arnsten, A.F.T., Chen, M., Godek, T.A., Dell, R.S.O., Naganawa, M., Harris, J.E., Bartlett, H.H., Nabulsi, N.B., Wyk, B.C. Vander, Varma, P., Huang, Y., Carson, R.E., Dyck, C.H. Van, 2020. In vivo measurement of widespread synaptic loss in Alzheimer \u2019 s disease with SV2A PET. Alzheimer\u2019s Dement. 974\u2013982. https:\/\/doi.org\/10.1002\/alz.12097.","DOI":"10.1002\/alz.12097"},{"key":"10.1016\/j.arr.2023.101998_bib152","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2023.101998_bib153","first-page":"1071","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.arr.2023.101998_bib154","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in Patients With Mild Cognitive Impairment Increases the Risk of Developing Dementia of Alzheimer Type: A Prospective Cohort Study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2023.101998_bib155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101998_bib156","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-Brain Barrier Breakdown in the Aging Human Hippocampus","volume":"85","author":"Montagne","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib157","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2017.08.031","article-title":"Emerging role of amyloid beta in stress response\u202f: Implication for depression and diabetes","volume":"817","author":"Morgese","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib158","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-018-0611-4","article-title":"NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (A\u03b2) overexpressing mice","volume":"6","author":"M\u00fcller","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2023.101998_bib159","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2019.11.023","article-title":"Repeated stress induces a pro-inflammatory state, increases amygdala neuronal and microglial activation, and causes anxiety in adult male rats","volume":"84","author":"Munshi","year":"2020","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.arr.2023.101998_bib160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2011.05.047","article-title":"Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression - No influence of celecoxib treatment","volume":"134","author":"Musil","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2023.101998_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810254","article-title":"Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis","volume":"23","author":"Nidadavolu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib162","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s Disease with plaques and tangles: Intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib163","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/cells8030209","article-title":"Presenilins and \u03b3-Secretase in Membrane Proteostasis","volume":"8","author":"Oikawa","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2023.101998_bib164","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of Antidepressants for Depression in Alzheimer\u2019s Disease: Systematic Review and Meta-Analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib166","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2014.04.007","article-title":"Microglial NLRP3 inflammasome activation mediates IL-1\u03b2-related inflammation in prefrontal cortex of depressive rats","volume":"41","author":"Pan","year":"2014","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.arr.2023.101998_bib167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2011.08.006","article-title":"Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims","volume":"46","author":"Pandey","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.arr.2023.101998_bib168","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.101998_bib169","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/gps.1828","article-title":"The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation","volume":"23","author":"Passmore","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib170","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","article-title":"Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer\u2019s disease","volume":"93","author":"Peng","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2023.101998_bib171","doi-asserted-by":"crossref","unstructured":"Pertwee, R.G., 2008. The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: \u0394 9-tetrahydrocannabinol, cannabidiol and \u0394 9-tetrahydrocannabivarin. Br. J. Pharmacol. 153, 199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","DOI":"10.1038\/sj.bjp.0707442"},{"key":"10.1016\/j.arr.2023.101998_bib172","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1007\/s12035-015-9522-6","article-title":"Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer\u2019 s Disease","volume":"53","author":"Petrov","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib173","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mad.2015.08.005","article-title":"Age-related changes in the endocannabinoid system in the mouse hippocampus","volume":"150","author":"Piyanova","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2023.101998_bib174","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0306-9877(02)00380-8","article-title":"Does increased platelet release of A\u03b2 peptide contribute to brain abnormalities in individuals with depression?","volume":"60","author":"Pomara","year":"2003","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.arr.2023.101998_bib175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.npp.1301234","article-title":"GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression","volume":"32","author":"Rajkowska","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2023.101998_bib176","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib177","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JGP.0b013e31816029ec","article-title":"Increased neurofibrillary tangles in patients with alzheimer disease with comorbid depression","volume":"16","author":"Rapp","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib178","article-title":"Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer\u2019s Disease","author":"Rathod","year":"2023","journal-title":"Curr. drug Res. Rev."},{"key":"10.1016\/j.arr.2023.101998_bib179","doi-asserted-by":"crossref","first-page":"e2648","DOI":"10.1212\/WNL.0000000000010739","article-title":"Association of amyloid-\u03b2 CSF\/PET discordance and tau load 5 years later","volume":"95","author":"Reimand","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.101998_bib180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.nbd.2015.03.011","article-title":"Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, Bipolar disorder, and major depressive disorder","volume":"77","author":"Reinhart","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2023.101998_bib181","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib182","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bph.12120","article-title":"The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis","volume":"169","author":"Romano","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib183","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-161102","article-title":"Alzheimer\u2019s Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches","volume":"57","author":"R\u00fcb","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib184","doi-asserted-by":"crossref","unstructured":"Rubino, T., Vigan\u00f2, D., Premoli, F., Castoglioni, C., Bianchessi, S., Zippel, R., Parolaro, D., 2006. Changes in the Expression of G Protein-Coupled Receptor Kinases and \u03b2-Arrestins in Mouse Brain During Cannabinoid Tolerance. Mol. Neurobiol. 33, 199\u2013213. https:\/\/doi.org\/10.1385\/mn:33:3:199.","DOI":"10.1385\/MN:33:3:199"},{"key":"10.1016\/j.arr.2023.101998_bib185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2016.06.035","article-title":"Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy","volume":"205","author":"Rush","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2023.101998_bib186","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib187","unstructured":"S. Gauthier P. Rosa-Neto J.A. Morais C. Webster World Alzheimer Report 2021: Journey through the diagnosis of dementia Engl. Alzheimer\u2019s Dis. Int. 2021 London."},{"key":"10.1016\/j.arr.2023.101998_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22354-2","article-title":"Association of sleep duration in middle and old age with incidence of dementia","volume":"12","author":"Sabia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.101998_bib189","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/WNL.0b013e3181e62138","article-title":"Depressive symptoms and risk of dementia: The Framingham Heart Study","volume":"75","author":"Saczynski","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.101998_bib190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pnpbp.2018.06.002","article-title":"Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels","volume":"86","author":"Sales","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib191","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients with Early Alzheimer Disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.arr.2023.101998_bib192","doi-asserted-by":"crossref","unstructured":"Sanacora, G., Gueorguieva, R., Epperson, C.N., Wu, Y. Te, Appel, M., Rothman, D.L., Krystal, J.H., Mason, G.F., 2004. Subtype-specific alterations of \u03b3-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61, 705\u2013713. https:\/\/doi.org\/10.1001\/archpsyc.61.7.705.","DOI":"10.1001\/archpsyc.61.7.705"},{"key":"10.1016\/j.arr.2023.101998_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173875","article-title":"Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer\u2019s disease","volume":"895","author":"S\u00e1nchez Montero","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib194","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2023.101998_bib195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2023.101998_bib196","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1007\/s12035-019-1637-8","article-title":"Efficacy of Cannabinoids in a Pre-clinical Drug Screening Platform for Alzheimer\u2019s Disease","volume":"56","author":"Schubert","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib197","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phyther. Res."},{"key":"10.1016\/j.arr.2023.101998_bib198","first-page":"301","article-title":"Deficiency in Mural Vascular Cells Coincides with Blood\u2013Brain Barrier Disruption in Alzheimer\u2019s Disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathlogy"},{"key":"10.1016\/j.arr.2023.101998_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13111975","article-title":"Antidepressants and Circadian Rhythm : Exploring Their Bidirectional Interaction for the Treatment of Depression","volume":"13","author":"Silva","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2023.101998_bib200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, Aducanumab, and Gantenerumab \u2014 Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer\u2019s Disease","volume":"20","author":"S\u00f6derberg","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.101998_bib201","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101998_bib202","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s12035-014-8958-4","article-title":"Brain-Derived Neurotrophic Factor in Alzheimer\u2019s Disease","volume":"52","author":"Song","year":"2015","journal-title":"Risk , Mechanismsand Therapy. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib203","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1111\/bph.15185","article-title":"A systematic review of minor phytocannabinoids with promising neuroprotective potential","volume":"177","author":"Stone","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02595-8","article-title":"Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer\u2019s disease pathology and in human post-mortem brain samples","volume":"19","author":"St-Pierre","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2023.101998_bib205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bpa.12289","article-title":"Precortical Phase of Alzheimer\u2019s Disease (AD)-Related Tau Cytoskeletal Pathology","volume":"26","author":"Stratmann","year":"2016","journal-title":"Brain Pathol"},{"key":"10.1016\/j.arr.2023.101998_bib206","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tips.2019.07.008","article-title":"Neuro-regeneration Therapeutic for Alzheimer\u2019s Dementia: Perspectives on Neurotrophic Activity","volume":"40","author":"Sun","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib207","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib208","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1306832110","article-title":"A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2023.101998_bib209","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-\u03b2 signaling promotes neurodegeneration and Alzheimer\u2019s pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2023.101998_bib210","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/1570159X14666160414111821","article-title":"Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System","volume":"15","author":"Todorova","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.00693","article-title":"Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by A \u03b2 1-42 Oligomers in Mice\u202f: A Key Role of Transforming Growth Factor- \u03b2 1","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib212","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s13311-021-01143-1","article-title":"SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer\u2019s Disease","volume":"18","author":"Trujillo-Estrada","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.101998_bib213","first-page":"1","article-title":"Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls A meta-Analysis and review under guideline of prisma","volume":"95","author":"Tu","year":"2016","journal-title":"Med. (United States)"},{"key":"10.1016\/j.arr.2023.101998_bib214","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102492","article-title":"The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases","volume":"10","author":"Tudorancea","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2023.101998_bib215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/cn200114w","article-title":"Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington\u2019s Disease: Role of CB1 and CB2 receptors","volume":"3","author":"Valdeolivas","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib216","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0269881116665357","article-title":"Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial","volume":"31","author":"Van Den Elsen","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib217","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-2007-12401","article-title":"Increased circulating insulin-like growth factor-1 in late-onset Alzheimer\u2019s disease","volume":"12","author":"Vardy","year":"2007","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nan.12753","article-title":"Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer\u2019s disease","volume":"48","author":"Viejo","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib219","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tips.2006.08.006","article-title":"Role of the endocannabinoid system in depression and suicide","volume":"27","author":"Vinod","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2023.101998_bib220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nbd.2008.12.007","article-title":"Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer\u2019s brain is mediated by the JNK-AP1 signaling pathway","volume":"34","author":"Vukic","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2023.101998_bib221","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1073858420945964","article-title":"Dendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer\u2019s Disease","volume":"27","author":"Walker","year":"2021","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2023.101998_bib222","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2018.00255","article-title":"cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2023.101998_bib224","first-page":"1","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","author":"Wang","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-017-0178-z","article-title":"Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats","volume":"15","author":"Wang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2023.101998_bib226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature11617","article-title":"A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge","volume":"492","author":"Warden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.arr.2023.101998_bib227","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1532-5415.2005.53524.x","article-title":"Relationship between serum insulin-like growth factor-1 levels and Alzheimer\u2019s disease and vascular dementia","volume":"53","author":"Watanabe","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2023.101998_bib228","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-191242","article-title":"Chronic Treatment with 50 mg\/kg Cannabidiol Improves Cognition and Moderately Reduces A\u03b240 Levels in 12-Month-Old Male A\u03b2PPswe\/PS1\u0394E9 Transgenic Mice","volume":"74","author":"Watt","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.101998_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/NS20220086","article-title":"Amyloid-\u03b2 in Alzheimer\u2019s disease \u2013 front and centre after all?","volume":"7","author":"Weglinski","year":"2023","journal-title":"Neuronal Signal"},{"key":"10.1016\/j.arr.2023.101998_bib230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamaneurol.2013.4781","article-title":"Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia: The Framingham Heart Study","volume":"71","author":"Weinstein","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.arr.2023.101998_bib231","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/BST20220518","article-title":"Interactions between amyloid , amyloid precursor protein , and mitochondria","volume":"51","author":"Wilkins","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"296","key":"10.1016\/j.arr.2023.101998_bib232","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid Signaling in the Brain","volume":"80","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arr.2023.101998_bib233","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2012.06.011","article-title":"Activation of the CB2 receptor system reverses amyloid-induced memory deficiency","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101998_bib234","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s10571-021-01153-9","article-title":"Blood\u2013Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder","volume":"42","author":"Wu","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101998_bib235","doi-asserted-by":"crossref","unstructured":"Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J.H., Thomsen, E., Dugas, J., Pizzo, M.E., DeVos, S.L., Earr, T.K., Lin, C.C., Davis, S., Ha, C., Leung, A.W.S., Nguyen, H., Chau, R., Yulyaningsih, E., Lopez, I., Solanoy, H., Masoud, S.T., Liang, C. chi, Lin, K., Astarita, G., Khoury, N., Zuchero, J.Y., Thorne, R.G., Shen, K., Miller, S., Palop, J.J., Garceau, D., Sasner, M., Whitesell, J.D., Harris, J.A., Hummel, S., Gn\u00f6rich, J., Wind, K., Kunze, L., Zatcepin, A., Brendel, M., Willem, M., Haass, C., Barnett, D., Zimmer, T.S., Orr, A.G., Scearce-Levie, K., Lewcock, J.W., Di Paolo, G., Sanchez, P.E., 2022. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Mol. Neurodegener. 17, 1\u201329. https:\/\/doi.org\/10.1186\/s13024-022-00547-7.","DOI":"10.1186\/s13024-022-00547-7"},{"key":"10.1016\/j.arr.2023.101998_bib236","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/gps.4409","article-title":"High amyloid-\u03b2 deposition related to depressive symptoms in older individuals with normal cognition\u202f: a pilot study","volume":"31","author":"Yasuno","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2023.101998_bib237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2023.101998_bib238","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41401-018-0051-5","article-title":"Integrating endocannabinoid signaling in the regulation of anxiety and depression","volume":"40","author":"Yin","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2023.101998_bib239","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","article-title":"Depression as a Microglial Disease","volume":"38","author":"Yirmiya","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.arr.2023.101998_bib240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","article-title":"Pro- and anti-inflammatory cytokines expression in rat\u2019s brain and spleen exposed to chronic mild stress: Involvement in depression","volume":"225","author":"You","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2023.101998_bib241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2022.106404","article-title":"Pharmacological targeting of microglia dynamics in Alzheimer\u2019s disease: Preclinical and clinical evidence","volume":"184","author":"Yousefizadeh","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2023.101998_bib242","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT 1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2023.101998_bib243","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/hipo.23379","article-title":"Insulin-like growth factor 1 gene transfer for sporadic Alzheimer\u2019s disease: New evidence for trophic factor mediated hippocampal neuronal and synaptic recovery-based behavior improvement","volume":"31","author":"Zappa Villar","year":"2021","journal-title":"Hippocampus"},{"key":"10.1016\/j.arr.2023.101998_bib244","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.21037\/atm-21-3143","article-title":"Cannabinoid receptor agonist WIN55212-2 reduces unpredictable mild stress-induced depressive behavior of rats","volume":"9","author":"Zhong","year":"2021","journal-title":"Ann. Transl. Med."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:19:20Z","timestamp":1761592760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":244,"alternative-id":["S1568163723001575"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.101998","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Under the umbrella of depression and Alzheimer\u2019s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.101998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101998"}}